article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 Morgan, along withBofA Securities, Cowen, Credit Suisse, Nomura and RBC Capital Markets, Baird, Needham & Company, Oppenheimer & Co., Piper Sandler and Valuable Capital.

Pricing 113
article thumbnail

Procore Prices IPO, Starts Trading Today

socalTECH

Carpinteria-based construction management software developer Procore Technologies priced its IPO last night, saying it will sell 9,470,000 shares of its common stock at a price of $67.00 The IPO priced above the company's initial estimated IPO range, which was $60.00 The IPO was underwritten by Goldman Sachs & Co.,

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Evofem Prices $50M Offering

socalTECH

San Diego-based Evofem Biosciences, which is developing biopharmaceuticals for women's contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term warrant.

Pricing 113
article thumbnail

Sonendo Prices IPO, Starts Trading Today

socalTECH

Laguna Hills-based dental technology developer Sonendo priced its IPO late last night, saying that it will sell 7,800,000 shares of its common stock at $12.00 Sonendo develops systems which are used for cleaning and disinfection during root canal procedures. The IPO was underwritten by BofA Securities, Goldman Sachs & Co.

Pricing 113
article thumbnail

Procore Sets Initial Estimated IPO Pricing

socalTECH

Carpinteria-based construction management software developer Procore has set its estimated initial IPO pricing, saying in a filing today that it now expects an initial offering price of betweenn $60.00 Morgan, Barclays, Jefferies, Canaccord Genuity, KeyBanc Capital Markets, Oppenheimer & Co., and $65.00

Pricing 113
article thumbnail

GoodRx Sets IPO Pricing Range

socalTECH

Santa Monica-based GoodRx , a developer of a digital healthcare and prescriptions service, has set an IPO pricing range of between $24.00 and $28.00 The company is looking to raise as much as $1.1 billion through its IPO on the NASDAQ Global Select Market. GoodRx has filed to trade as GDRX. Seelaus & Co., LLC and Ramirez & Co.,

article thumbnail

Janux Therapeutics Prices IPO, Hits Nasdaq Today

socalTECH

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 Janux Therapeutics is developing T cell engager immunotherapies. Janux Therapeutics is developing T cell engager immunotherapies.

Pricing 113